Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PROCTER & GAMBLE CoPG · Entity 2814 | CEO - Health Care | March 01, 2022 | March 03, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PROCTER & GAMBLE Co
Report date March 01, 2022 · Filed March 03, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 28,156.0655 |
Reported balance
After 2022-03-01 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2022-03-01 · Sale · Disposed 3,730 · Balance 28,156.0655 F1: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 658.9166 |
Reported balance
After 2022-02-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2022-02-15 · Grant · Acquired 38.8111 · Balance 658.9166 F4: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. |
| Common StockSEC Table I · non-derivative | IndirectBy Retirement Plan Trustee | 5,886.2019 |
Reported balance
Holding disclosure · report date 2022-03-01 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 5,886.2019 F3: Reflects adjustment to PST through December 31, 2021. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 1,993.2817 |
Reported balance
Holding disclosure · report date 2022-03-01 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,993.2817 |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse, By Retirement Plan Trustees | 667.8403 |
Reported balance
Holding disclosure · report date 2022-03-01 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 667.8403 F3: Reflects adjustment to PST through December 31, 2021. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award.
F2: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock.
F3: Reflects adjustment to PST through December 31, 2021.
F4: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock.
F5: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
KELLANOVA
Report date December 11, 2025 · Filed December 11, 2025
Section 16 reporting ended · disclosed 2025-12-11. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | IndirectHeld in Trust | 0 |
Reported balance
After 2025-12-11 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2025-12-11 · Disposition to issuer · Disposed 29,302.171 · Balance 0 F1: Pursuant to the Agreement and Plan of Merger, dated as of August 13, 2024, by and among the Issuer, Acquiror 10VB8, LLC ("Acquiror"), Merger Sub 10VB8, LLC ("Merger Sub"), and solely for the limited purposes set forth therein, Mars, Incorporated, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Acquiror (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.25 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $83.50 per share in cash, without interest and subject to any applicable withholding taxes (the "Merger Consideration"). F2: Includes shares acquired under the Company's Dividend Reinvestment Plan in 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the Agreement and Plan of Merger, dated as of August 13, 2024, by and among the Issuer, Acquiror 10VB8, LLC ("Acquiror"), Merger Sub 10VB8, LLC ("Merger Sub"), and solely for the limited purposes set forth therein, Mars, Incorporated, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Acquiror (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.25 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $83.50 per share in cash, without interest and subject to any applicable withholding taxes (the "Merger Consideration").
F2: Includes shares acquired under the Company's Dividend Reinvestment Plan in 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 11, 2025 Filed Dec 11, 2025 18:35 UTC | KELLANOVA K · Entity 71752 | Disposition to issuerCommon | 29,302.171 | $83.50 | $2,446,731.28 |
DisclosureSEC source: 0001193125-25-316396 · ownership.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held in Trust Disclosed balance after: 0 F1 · kind: Pursuant to the Agreement and Plan of Merger, dated as of August 13, 2024, by and among the Issuer, Acquiror 10VB8, LLC ("Acquiror"), Merger Sub 10VB8, LLC ("Merger Sub"), and solely for the limited purposes set forth therein, Mars, Incorporated, Merger Sub merged with and into the Issuer, with the Issuer surviving as a wholly owned subsidiary of Acquiror (the "Merger"). At the effective time of the Merger (the "Effective Time"), upon the terms and subject to the conditions set forth in the Merger Agreement, each share of the Issuer's common stock, par value $0.25 per share ("Common Stock"), that was issued and outstanding immediately prior to the Effective Time was automatically cancelled and converted into the right to receive $83.50 per share in cash, without interest and subject to any applicable withholding taxes (the "Merger Consideration"). F2 · shares: Includes shares acquired under the Company's Dividend Reinvestment Plan in 2025. Read SEC document |
| May 05, 2025 Filed May 7, 2025 16:20 UTC | KELLANOVA K · Entity 71752 | GrantCommon | 2,119 | $82.61 | $175,050.59 |
DisclosureSEC source: 0000055067-25-000140 · wk-form4_1746649227.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held in Trust Disclosed balance after: 28,664.939 F1 · balance_after: Excludes dividends reinvested after January 1, 2025. Read SEC document |
| December 28, 2024 Filed Feb 6, 2025 16:18 UTC | KELLANOVA K · Entity 71752 | OtherCommon | 914.611 | $0.00 | $0.00 |
DisclosureSEC source: 0000055067-25-000027 · wk-form5_1738876681.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held in Trust Disclosed balance after: 26,545.939 F1 · kind: Shares acquired under the Company's Dividend Reinvestment Plan in 2024. Read SEC document |
| May 06, 2024 Filed May 7, 2024 16:18 UTC | KELLANOVA K · Entity 71752 | GrantCommon | 2,915 | $60.04 | $175,016.60 |
DisclosureSEC source: 0001225208-24-005734 · doc4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held in Trust Disclosed balance after: 25,631.328 F1 · balance_after: Excludes dividends reinvested after January 1, 2024. Read SEC document |
| December 30, 2023 Filed Feb 9, 2024 16:57 UTC | KELLANOVA K · Entity 71752 | OtherCommon | 849.496 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-001830 · doc5.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held in Trust Disclosed balance after: 22,716.328 F1 · kind: Shares acquired under the Company's Dividend Reinvestment Plan in 2023. Read SEC document |
| May 08, 2023 Filed May 10, 2023 16:19 UTC | KELLANOVA K · Entity 71752 | GrantCommon | 2,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-005674 · doc4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held in Trust Disclosed balance after: 21,766.832 F1 · balance_after: Excludes dividends reinvested after January 1, 2023. Read SEC document |
| May 08, 2023 Filed Jul 12, 2023 16:18 UTC Amendment | KELLANOVA K · Entity 71752 | GrantCommon | 2,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-007466 · doc4a.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · Held in Trust Disclosed balance after: 21,866.832 F1 · shares: The original Form 4 inadvertently understated the number of shares of common stock issued to the reporting person by 100 shares. The corrected number is reflected in this amendment. F2 · balance_after: Excludes dividends reinvested after January 1, 2023. Read SEC document |
| December 31, 2022 Filed Feb 10, 2023 16:24 UTC | KELLANOVA K · Entity 71752 | OtherCommon | 647.002 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001661 · doc5.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 19,686.832 F1 · kind: Shares acquired under the Company's Dividend Reinvestment Plan in 2022. Read SEC document |
| May 09, 2022 Filed May 10, 2022 16:18 UTC | KELLANOVA K · Entity 71752 | GrantCommon | 2,080 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-006764 · doc4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 19,039.83 F1 · balance_after: Excludes dividends reinvested after January 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 14:54 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 3,730 | $153.51 | $572,596.78 |
DisclosureSEC source: 0001127602-22-007874 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,156.0655 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 15, 2022 Filed Mar 3, 2022 14:54 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 38.8111 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-007874 · form4.xml · derivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 658.9166 Underlying: Common Stock · 38.8111 shares Expires not disclosed F4 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F5 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F5 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| January 01, 2022 Filed Feb 11, 2022 16:24 UTC | KELLANOVA K · Entity 71752 | OtherCommon | 586.14 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-001902 · doc5.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 16,959.83 F1 · kind: Shares acquired under the Company's Dividend Reinvestment Plan in 2021. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 18:44 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionRestricted Stock Units · Derivative | 62.7432 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030431 · form4.xml · derivative · entry 9 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 818.2568 Underlying: Common Stock · 62.7432 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent the contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2021. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 18:44 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Tax withholdingCommon Stock | 42.2483 | $148.83 | $6,287.79 |
DisclosureSEC source: 0001127602-21-030431 · form4.xml · nonDerivative · entry 4 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,717.9734 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grants. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 18:44 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Tax withholdingCommon Stock | 170.0039 | $148.83 | $25,301.60 |
DisclosureSEC source: 0001127602-21-030431 · form4.xml · nonDerivative · entry 3 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,760.2217 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grants. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 18:44 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Tax withholdingCommon Stock | 62.7432 | $148.83 | $9,338.04 |
DisclosureSEC source: 0001127602-21-030431 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,930.2256 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grants. Read SEC document |
| December 06, 2021 Filed Dec 7, 2021 18:44 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 62.7432 | $148.83 | $9,338.04 |
DisclosureSEC source: 0001127602-21-030431 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,992.9688 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| November 15, 2021 Filed Dec 7, 2021 18:44 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 39.4004 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-030431 · form4.xml · derivative · entry 8 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 620.1055 Underlying: Common Stock · 39.4004 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:04 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantStock Option (Right to Buy) · Derivative | 62,731 | $0.00 Strike: $139.58 | $0.00 |
DisclosureSEC source: 0001127602-21-026608 · form4.xml · derivative · entry 6 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,731 Underlying: Common Stock · 62,731 shares Expires 2031-10-01 Read SEC document |
| October 01, 2021 Filed Oct 5, 2021 15:04 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 3,251 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026608 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,748.3632 F1 · price: Restricted Stock Units awarded pursuant to Issuer's 2019 Stock and Incentive Compensation Plan. Read SEC document |
| September 15, 2021 Filed Sep 16, 2021 18:35 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantStock Option (Right to Buy) · Derivative | 72,862 | $0.00 Strike: $145.12 | $0.00 |
DisclosureSEC source: 0001127602-21-025393 · form4.xml · derivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,862 Underlying: Common Stock · 72,862 shares Expires 2031-09-15 Read SEC document |
| August 19, 2021 Filed Aug 19, 2021 23:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 15,456 | $143.90 | $2,224,118.40 |
DisclosureSEC source: 0001127602-21-024067 · form4.xml · nonDerivative · entry 3 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,497.3632 Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 12,696 | $144.37 | $1,832,934.22 |
DisclosureSEC source: 0001127602-21-024067 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,953.3632 F3 · shares: Shares sold to cover taxes on Stock Award. F4 · price: Weighted average price of the shares sold. The price range was $143.885 to $144.81. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 23:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantCommon Stock | 28,152 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024067 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,649.3632 F1 · price: Stock award pursuant to issuer's 2019 Stock and Incentive Compensation Plan. F2 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| August 16, 2021 Filed Aug 19, 2021 23:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 37.0937 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024067 · form4.xml · derivative · entry 7 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 580.7051 Underlying: Common Stock · 37.0937 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F6 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F6 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 05, 2021 Filed Aug 9, 2021 20:23 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 881 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-023345 · form4.xml · derivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 881 Underlying: Common Stock · 881 shares Expires not disclosed F1 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent the contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2021. F2 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F2 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| August 02, 2021 Filed Aug 2, 2021 22:16 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 7,772 | $141.77 | $1,101,836.44 |
DisclosureSEC source: 0001127602-21-022804 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,332.9992 Read SEC document |
| July 19, 2021 Filed Oct 5, 2021 15:04 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantSeries A Preferred Stock · Derivative | 124.1349 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-026608 · form4.xml · derivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · CEO - Health Care 10b5-1 filing: Not disclosed Ownership: Indirect · By Retirement Plan Trustee Disclosed balance after: 3,972.4278 Underlying: Common Stock · 124.1349 shares Expires not disclosed F3 · derivative.exercise_price: Higher of $6.82 (adjusted for 2-for-1 stock split effective May 21, 2004) or market price of Common Stock. F4 · derivative.exercise_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. F4 · derivative.expiration_date: Shares held by Retirement Plan Trustees. If Officer terminates employment and elects distribution of shares, or, if after age 50 elects alternative investment within Plan, Preferred Stock converted/redeemed at specified conversion/exercise price. Read SEC document |
| May 26, 2021 Filed May 27, 2021 20:41 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 3,000 | $138.20 | $414,600.00 |
DisclosureSEC source: 0001127602-21-018191 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,104.9992 F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| May 17, 2021 Filed May 27, 2021 20:41 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 38.3804 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-018191 · form4.xml · derivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581.9918 Underlying: Common Stock · 38.3804 shares Expires not disclosed F2 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F3 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F3 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| May 11, 2021 Filed May 13, 2021 20:19 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 3,513 | $137.27 | $482,242.86 |
DisclosureSEC source: 0001127602-21-016564 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,935.7086 Read SEC document |
| May 10, 2021 Filed May 11, 2021 16:19 UTC | KELLANOVA K · Entity 71752 | GrantCommon | 2,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-007957 · doc4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 16,373.69 F1 · balance_after: Excludes dividends reinvested after January 1, 2021. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 19:59 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 1,219 | $125.77 | $153,315.34 |
DisclosureSEC source: 0001127602-21-008051 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,448.7086 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $124.58 to $126.54. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| February 26, 2021 Filed Feb 26, 2021 19:59 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 6,661 | $125.77 | $837,763.30 |
DisclosureSEC source: 0001127602-21-008051 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,667.7086 F1 · shares: Shares sold to cover tax obligations upon settlement of Restricted Stock Unit award. F2 · price: Weighted average price of the shares sold. The price range was $124.58 to $126.54. Full information regarding the number of shares sold at each separate price available upon request. F3 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| February 16, 2021 Filed Feb 26, 2021 19:59 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 37.5994 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-008051 · form4.xml · derivative · entry 6 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 543.6114 Underlying: Common Stock · 37.5994 shares Expires not disclosed F5 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F6 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F6 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| January 02, 2021 Filed Feb 12, 2021 16:43 UTC | KELLANOVA K · Entity 71752 | OtherCommon | 469.324 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002405 · doc5.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Held in Trust Disclosed balance after: 14,100.69 F1 · kind: Shares acquired under the Company's Dividend Reinvestment Plan in 2020. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 18:57 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionRestricted Stock Units · Derivative | 67.3704 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031737 · form4.xml · derivative · entry 10 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 880.6296 Underlying: Common Stock · 67.3704 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Retirement award in the form of Restricted Stock Units which represent the contingent right to receive P&G common stock or cash settlement. Amount and price computed per benefit formula for plan year ended 6/30/2020. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 18:57 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Tax withholdingCommon Stock | 257.4153 | $136.85 | $35,227.28 |
DisclosureSEC source: 0001127602-20-031737 · form4.xml · nonDerivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,133.7229 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grants. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 18:57 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Tax withholdingCommon Stock | 43.2377 | $136.85 | $5,917.08 |
DisclosureSEC source: 0001127602-20-031737 · form4.xml · nonDerivative · entry 4 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,391.1382 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grants. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 18:57 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Tax withholdingCommon Stock | 67.3704 | $136.85 | $9,219.64 |
DisclosureSEC source: 0001127602-20-031737 · form4.xml · nonDerivative · entry 3 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,434.3759 F2 · shares: Shares withheld to cover taxes on previous Restricted Stock Unit grants. Read SEC document |
| December 15, 2020 Filed Dec 17, 2020 18:57 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 67.3704 | $136.85 | $9,219.64 |
DisclosureSEC source: 0001127602-20-031737 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,501.7463 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Total includes grant of dividend equivalents in the form of Restricted Stock Units (RSU's) settled in common stock. Read SEC document |
| November 16, 2020 Filed Dec 17, 2020 18:57 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantRestricted Stock Units · Derivative | 33.725 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031737 · form4.xml · derivative · entry 9 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 506.012 Underlying: Common Stock · 33.725 shares Expires not disclosed F3 · derivative.exercise_price: Dividend equivalents in the form of Restricted Stock Units (RSUs) previously awarded pursuant to issuer's retirement program. All such RSUs represent a contingent right to receive Procter & Gamble common stock. F4 · derivative.exercise_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. F4 · derivative.expiration_date: These units will deliver in shares on retirement from the company, unless delivery is deferred or such shares are contributed to reporting person's deferred compensation account. Read SEC document |
| November 12, 2020 Filed Dec 17, 2020 18:57 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GiftCommon Stock | 700 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-031737 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,259.749 Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionStock Option (Right to Buy) · Derivative | 30,371 | $0.00 Strike: $69.45 | $0.00 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · derivative · entry 10 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,371 shares Expires 2025-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionStock Option (Right to Buy) · Derivative | 21,496 | $0.00 Strike: $83.87 | $0.00 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · derivative · entry 9 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 21,496 shares Expires 2024-09-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 30,371 | $142.94 | $4,341,157.85 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · nonDerivative · entry 4 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,959.749 F1 · price: Weighted average price of the shares sold. The price range was $142.70 to $143.22. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 30,371 | $69.45 | $2,109,265.95 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · nonDerivative · entry 3 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,330.749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | SaleCommon Stock | 21,496 | $142.94 | $3,072,586.65 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · nonDerivative · entry 2 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,959.749 F1 · price: Weighted average price of the shares sold. The price range was $142.70 to $143.22. Full information regarding the number of shares sold at each separate price available upon request. Read SEC document |
| October 27, 2020 Filed Oct 28, 2020 12:38 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | Exercise / conversionCommon Stock | 21,496 | $83.87 | $1,802,869.52 |
DisclosureSEC source: 0001127602-20-027592 · form4.xml · nonDerivative · entry 1 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,455.749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 15:26 UTC | PROCTER & GAMBLE Co PG · Entity 2814 | GrantStock Option (Right to Buy) · Derivative | 58,438 | $0.00 Strike: $139.24 | $0.00 |
DisclosureSEC source: 0001127602-20-026456 · form4.xml · derivative · entry 5 TASTAD CAROLYN M · CIK 0001597938 · Group Pres-Chief Sales Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,438 Underlying: Common Stock · 58,438 shares Expires 2030-10-01 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.